Nuvectis Pharma Income Statement (2021-2026) | NVCT

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
4.25M4.16M1.14M0.86M2.50M4.52M4.40M2.37M4.26M4.49M4.26M2.66M2.94M2.82M4.50M3.68M3.61M5.77M5.09M4.11M
Selling, General & Administrative (Quarter)
1.69M0.51M1.12M1.14M1.07M1.42M2.38M1.73M1.51M1.67M2.60M1.74M1.70M1.54M1.95M1.89M2.98M2.02M2.53M2.15M
Operating Expenses (Quarter)
5.94M4.67M2.27M2.00M3.57M5.94M6.78M4.10M5.77M6.16M6.87M4.40M4.64M4.36M6.45M5.57M6.59M7.79M7.62M6.26M
Operating Income (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.94M-6.78M-4.10M-5.77M-6.16M-6.87M-4.40M-4.64M-4.36M-6.45M-5.57M-6.59M-7.79M-7.62M-6.26M
EBIT (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.94M-6.78M-4.10M-5.77M-6.16M-6.87M-4.40M-4.64M-4.36M-6.45M-5.57M-6.59M-7.79M-7.62M-6.26M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.00M0.06M0.08M0.05M0.06M0.28M0.24M0.23M0.21M0.21M0.20M0.24M0.26M0.33M0.30M0.21M
Net income details
EBT (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-7.46M-7.31M-6.05M
Profit After Tax (Quarter)
-5.94M-4.67M-2.26M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-7.46M-7.31M-6.05M
Income from Continuing Operations (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-7.46M-7.31M-6.05M
Consolidated Net Income (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-7.46M-7.31M-6.05M
Income towards Parent Company (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-7.46M-7.31M-6.05M
Net Income towards Common Stockholders (Quarter)
-5.94M-4.67M-2.26M-2.94M-3.57M-5.88M-6.70M-4.05M-5.71M-5.88M-6.62M-4.17M-4.43M-4.15M-6.25M-5.33M-6.33M-9.89M-7.31M-6.05M
Additional items
EPS (Basic) (Quarter)
-1.43-1.04-0.48-0.32-0.28-0.42-0.48-0.27-0.38-0.37-0.41-0.25-0.26-0.24-0.36-0.27-0.30-0.44-0.31-0.26
EPS (Weighted Average and Diluted) (Quarter)
-1.43-1.04-0.48-0.32-0.28-0.42-0.48-0.27-0.38-0.37-0.41-0.25-0.26-0.24-0.36-0.27-0.30-0.44-0.31-0.26
Shares Outstanding (Weighted Average) (Quarter)
4.16M4.19M4.27M9.16M10.98M11.99M12.66M14.72M14.95M16.10M15.56M17.93M16.73M17.23M17.11M19.94M20.66M21.35M21.81M26.45M
Shares Outstanding (Diluted Average) (Quarter)
4.16M4.19M4.27M9.16M12.72M11.99M12.66M14.72M15.18M16.10M15.56M16.56M16.90M16.90M17.11M19.94M20.66M22.72M21.81M23.41M
EBITDA (Quarter)
-5.94M-4.67M-2.27M-2.94M-3.57M-5.94M-6.78M-4.10M-5.77M-6.16M-6.87M-4.40M-4.64M-4.36M-6.45M-5.57M-6.59M-7.79M-7.62M-6.26M
Shares Outstanding (Quarter)
4.51M4.51M4.75M12.72M12.72M14.64M15.19M15.89M17.22M17.31M17.42M18.36M18.75M18.99M19.50M23.63M23.88M25.64M25.68M26.53M